Skip to content

Kyndryl Holdings KD Accrued Liabilities And Other Liabilities Current

Accrued Liabilities And Other Liabilities Current at other companies

PVL
Palvella TherapeuticsPVLA
$3.46M+35.1%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$33.68M-26.0%
Veeco Instruments logo
Veeco InstrumentsVECO
$52.04M-16.4%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$42.85M+27.7%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$23.9M-1.8%
Chime Financial, Inc. Class A Common Stock logo
Chime Financial, Inc. Class A Common StockCHYM
$185.04M

Other financials

Income statement

See full
Revenue$3.8B-0.8%
Gross profit$849.0M+2.9%
Net income$17.0M-75.4%
EPS (diluted)$0.08-71.4%

Balance sheet

See full
Cash & equivalents$2.6B+46.9%
Total debt$5.2B+22.4%
Total equity$1.2B-3.6%
Total assets$12.6B+20.1%

Cash flow

See full
Operating cash flow$498.0M-14.3%
CapEx$116.0M-51.7%
Free cash flow$382.0M+12.0%

Valuation

See full
Market cap$2.45B-59.5%
Enterprise value$4.98B-43.6%
P/E12.4×-11.7×
P/S0.2×-0.2×

Profitability

See full
Gross margin21.8%+0.9pp
Net margin1.3%-0.4pp
FCF margin-3%

Returns & leverage

See full
Return on equity16.5%-6.0pp
Debt / equity4.4×+0.9×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Kyndryl Holdings in its filing.

Tagged under the XBRL concept kd:AccruedLiabilitiesAndOtherLiabilitiesCurrent.

The official record: Kyndryl Holdings’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyndryl Holdings's accrued liabilities and other liabilities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kyndryl Holdings's accrued liabilities and other liabilities current?
Kyndryl Holdings (KD) reported accrued liabilities and other liabilities current of $903M in Q1 2026.
How has Kyndryl Holdings's accrued liabilities and other liabilities current changed year-over-year?
Kyndryl Holdings's accrued liabilities and other liabilities current increased by 98.9% year-over-year, from $454M to $903M.
What is the long-term trend for Kyndryl Holdings's accrued liabilities and other liabilities current?
Over 4 years (2022 to 2026), Kyndryl Holdings's accrued liabilities and other liabilities current has grown at a 7.3% compound annual growth rate (CAGR), from $682M to $903M.
What does accrued liabilities and other liabilities current mean?
This captures short-term obligations that have been incurred but not yet invoiced or paid, excluding standard trade accounts payable. It typically includes items such as employee compensation, accrued professional fees, and other operational expenses necessary to support IT infrastructure services. Tracking this balance provides insight into the company's near-term operational commitments and the efficiency of its expense accrual processes.